Thank you for following our live blog today. All the materials from today’s event will be archived in the online press room. (Update: The speakers’ PowerPoints are now available.) We have a few more video interviews to post later today, so stay tuned.
We learned from our distinguished panelists that we are on the cusp of exciting new breakthroughs in HIV prevention that could really slow the spread of this devastating epidemic, including PreP. But due to flat funding for PEPFAR and the economic recession, we face a new crisis in HIV treatment access.
We were alerted that there is more TB in the world today than ever before, and yet the Obama Administration is backing away from aggressive treatment targets approved by Congress in 2008 as part of the Lantos-Hyde Act. . Similarly with TB, there are exciting new diagnostics and drugs in the pipeline that could revolutionize TB treatment. But without adequate funding or investment to implement those, prospects for providing treatment will diminish. This will cost much more, in dollars and in lives, down the line.
Brown Professor Kenneth Mayer urged advocates to think of new ways to ramp up support and enthusiasm. He called for a sense of urgency going forward. In June, Congress will be considering appropriations for the Obama Administrations’ budget request. The lives of millions of parents, children, health care workers, teachers, and many others are at stake.